+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Use of rabbits to test the pathogenicity and immunogenicity of a vaccine strain of Salmonella choleraesuis



Use of rabbits to test the pathogenicity and immunogenicity of a vaccine strain of Salmonella choleraesuis



Lucrarile Institutului de Cercetari Veterinare si Biopreparate ' Pasteur' 18: 23-28



This vaccinal strain was shown to be harmless in rabbits, which were used to establish a median protective dose.

(PDF emailed within 1 workday: $29.90)

Accession: 001997219

Download citation: RISBibTeXText



Related references

Vaccinal strain 237 SM (Salmonella choleraesuis). Pathogenicity and immunogenicity testing through experimental infection and (hyper)immunization of HPCDIR piglets. Studies and Researches in Veterinary Medicine 1(1): 13-16, 1992

Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice. Wei Sheng Wu Xue Bao 51(9): 1270-1277, 2012

Immunogenicity of the attenuated Salmonella choleraesuis strain 237 Sm I for pigs. I. Pathogenicity and stability after repeated passage in pigs. Lucr. Inst. Cerc. Vet. Bioprep. Pasteur. 2: 1, 265-276, 1965

Salmonella cholerae suis vaccinal strain 237 sm tested for pathogenicity and immunogenicity in rabbits. Lucrarile Institutului de Cercetari Veterinare si Biopreparate Pasteur 18: 23-28, 1988

Active immunization of pigs against Salmonella choleraesuis with an inactivated, commercially available vaccine (Dessau Salmonella choleraesuis adsorbed vaccine. Archiv fur experimentelle Veterinarmedizin: 27 (2) 233-237, 1973

Immunization of mice and rabbits with the chrome vaccine against Salmonella choleraesuis infection. Japanese Jour Bact 9(10): 849-852, 1954

Live vaccine against swine paratyphoid from the attenuated smooth strain C 500 of Salmonella choleraesuis. Collected papers of veterinary research Volume 4: 1-13, 1978

Salmonella Pathogenicity Island 2 mutants of Salmonella as vaccine vectors Immunogenicity of a heterologous antigen expressed from the chromosome under the control of in vivo-inducible promoters. Abstracts of the General Meeting of the American Society for Microbiology 101: 338-339, 2001

Preliminary study on the recombinant live vaccine against FMDV type O delivered by attenuated Salmonella choleraesuis in rabbits. Fudan Xuebao Zirankexueban 44(4): 484-489, 2005

Complete Genome Sequence of Salmonella enterica Serovar Choleraesuis Vaccine Strain C500 Attenuated by Chemical Mutation. Genome Announcements 2(5): -, 2014

Construction of attenuated Salmonella choleraesuis vaccine strain expressing recombinant antigen of Shiga-like toxin Escherichia coli. Wei Sheng Wu Xue Bao 49(4): 518-523, 2009

Construction and characterization of recombinant Salmonella enterica serovar choleraesuis vaccine strain expressing heterologous antigen of Pasteurella multocida toxin. Wei Sheng Wu Xue Bao 50(1): 91-97, 2010

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. Journal of Infectious Diseases 169(4): 927-931, 1994

Identification of Salmonella pathogenicity island 2 genes in Salmonella choleraesuis using signature-tagged mutagenesis. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 76, 1997